George Pentheroudakis
@gpentheroudakis
Chief Medical Officer, ESMO
ID: 1130178669165580289
19-05-2019 18:29:27
320 Tweet
381 Followers
86 Following
Keynote lecture by Myriam Chalabi at #ESMOGI24 ☑️ is there room for #immunotherapy in MSS colorectal cancer❓
#ESMOGI24: Do recent advances offer hope for mismatch repair-proficient and MSS #CRC pts who have a lower mutational burden and have historically been less responsive to immunotherapy? Read the opinion by Myriam Chalabi on #ESMODailyReporter to find out 📌ow.ly/Xqzl50SqFST
Beautiful discussion by Chiara Cremolini on therapeutic options for patients with #CRC from liver transplant to immunotherapy to later line options #ESMOGI24 #ESMOAmbassadors ESMO - Eur. Oncology
Keynote address at #ESMOGI24 with superstar Myriam Chalabi - Immunotherapy for MSS-CRC: The last frontier ESMO - Eur. Oncology OncoAlert The Netherlands Cancer Institute
Final part of the ESMO - Eur. Oncology Leaders Generation Programme ‘23-24 - Jon Lim Ilaria Colombo Marc Oliva Valentina Gambardella Brent O'Carrigan Elie Rassy oncodaily.com/91864.html #Cancer #ESMO24 #OncoDaily #Oncology
I think it was clear during #ESMOGI24 that ESMO - Eur. Oncology supports #GastrointestinalCancers and Andres Cervantes made it clear in his closing remarks. Examples 👉ESMO Guidelines in GI 👉Living guidelines 👉MCBS 👉Dedicated conference and journal #ESMOAmbassadors
Looking forward to a fantastic ESMO - Eur. Oncology #esmo24 with fantastic speakers, excellent content, collaboration, exchange, mentorship & networking! Andres Cervantes George Pentheroudakis silke gillessen Tom Powles Toni Choueiri, MD FabriceAndre Matteo Lambertini, MD PhD Laurence Albiges ylt Shilpa Gupta OncoAlert
Advances in #PrecisionOncology are moving the field towards biology-based #CancerCare: ESMO is supporting the change with a series of tailored resources for medical oncologists. Read FabriceAndre interview in the #ESMODailyReporter 👉ow.ly/Sn4350T7ptt